Doctors Get New Clinical Guidelines for Managing Chronic Pain With Cannabis, Courtesy of Canadian Researchers
by Bethan Rose
After a strong 2021, all signs are pointing to an even bigger year for the cannabis industry in 2022. According to a report from Marijuana Business Daily, U.S. legal cannabis sales are predicted to surpass $30 billion in 2022. The number may seem high, but there are plenty of reasons experts believe the prediction will be spot on.
For starters, American support of cannabis, already at a record high, will only increase as cannabis becomes more accessible. A Gallup poll from 2021 revealed that around 68% of Americans were in support of cannabis legalization.
The poll highlighted how accessibility and education about cannabis have begun to peel away old stigmas surrounding the plant. With more states entering the legal market in 2022, experts expect cannabis to become even more socially acceptable.
Accessibility isn’t just great for consumers either. Another large part of experts’ optimistic forecast for cannabis is an increase in research about the plant. Before 1999, there were fewer than 5,000 published studies on cannabis. In 2020 alone the number of cannabis studies was over 3,500.
2022 is looking to be an even bigger year for cannabis research, featuring exciting studies like one on non-THC and CBD cannabinoids by Colorado State University. Studies like this one not only help to further destigmatize cannabis, but they can also lead to the creation of new and more effective cannabis products.
Between growing cannabis accessibility and education, there is no limit to the heights this skyrocketing industry may reach this year.
“Do you prefer an indica or a sativa?” is typically the first question asked at a dispensary. Indica vs. sativa refers to the two main categories of cannabis strains. Both indicas and sativas differ in appearance and effects. Indicas are generally known for a sedating effect, while sativa strains are known for a cerebral high….
Cancer can be a harrowing journey, not only due to the disease itself but also because of the relentless pain that often accompanies it. Conventional pain management strategies, such as opioids and other medications, can sometimes fall short in providing lasting relief or cause undesirable side effects. But what if a safe and effective complementary…
A bill was passed to legalize the possession and sharing of certain psychedelics for Californians aged 21 and above. The bill underwent an accelerated process that allowed it to bypass further committee consideration; thus, it was moved directly to the Senate floor. The legislation was sponsored by Sen. Scott Wiener (D), and he explained that…
The U.S. Secret Service (USSS) recently loosened its applicant drug use policy to be more accommodating to past cannabis consumers. Candidates of all ages can now apply to join the agency if they have abstained from marijuana for one year before applying. Before this policy, cannabis use within the past three years led to automatic disqualification. …
Tara Davis-Woodhall, a 23-year-old U.S. long jumper, was stripped of the national indoor title she obtained in February after testing positive for THC. As announced by the US Anti-Doping Agency (USADA), she has been suspended for a month. The sample was collected on Feb. 17 at the 2023 USA Track and Field (USATF) indoor championships…
It was 1978. Nearly a decade after the Stonewall riots, the fight for LGBTQIA+ rights was still in full swing. The world…
Currently, numerous scientific studies support using cannabis for pain and inflammation. For example, a noteworthy study published by the Journal of the…
June is Alzheimer’s and Brain Awareness Month, and we’re diving into the role of cannabis in brain health. In today’s fast-paced world,…